Chromosome 22q12.1 microdeletions: Confirmation of the MN1 gene as a candidate gene for cleft palate

European Journal of Human Genetics

Volumn 24, Issue 1, 2016, Pages 51-58

  Breckpot, Jeroen ^a   Anderlid, Britt Marie ^b   Alanay, Yasemin ^c   Blyth, Moira ^d   Brahimi, Afane ^e   Duban Bedu, Bénédicte ^e   Gozé, Odile ^f   Firth, Helen ^g   Yakicier, Mustafa Cengiz ^c   Hens, Greet ^a   Rayyan, Maissa ^a   Legius, Eric ^a   Vermeesch, Joris Robert ^a   Devriendt, Koen ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ACIBADEM UNIVERSITY   (Turkey)

^d CHAPEL ALLERTON HOSPITAL   (United Kingdom)

^e HÔPITAL SAINT VINCENT DE PAUL   (France)

^f CENTRE HOSPITALIER DE VALENCIENNES   (France)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CEPHALOMETRY; CHILD; CHROMOSOME 22Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DELETION 22Q12; CLEFT PALATE; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL HEART MALFORMATION; CORPUS CALLOSUM AGENESIS; DEVELOPMENTAL DISORDER; FACE DYSMORPHIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DOSAGE; GENETIC SCREENING; HEARING IMPAIRMENT; HUMAN; MALE; MN1 GENE; MUTATIONAL ANALYSIS; NEURILEMOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VESTIBULAR NERVE; YOUNG ADULT; ADOLESCENT; AGENESIS OF CORPUS CALLOSUM; ANIMAL; CASE REPORT; CHROMOSOMAL MAPPING; CHROMOSOME 22; DEFICIENCY; DNA SEQUENCE; GENE EXPRESSION; GENETICS; HAPLOINSUFFICIENCY; KNOCKOUT MOUSE; METABOLISM; MOUSE; NEUROMA, ACOUSTIC;

MN1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; AGENESIS OF CORPUS CALLOSUM; ANIMALS; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 22; CLEFT PALATE; FEMALE; GENE EXPRESSION; HAPLOINSUFFICIENCY; HUMANS; MALE; MICE; MICE, KNOCKOUT; NEUROMA, ACOUSTIC; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS;

EID: 84951573664     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2015.65     Document Type: Article

References (32)

1. Levi B, Brugman S, Wong VW, Grova M, Longaker MT, Wan DC. Palatogenesis: engineering, pathways and pathologies. Organogenesis 2011; 7: 242-254
2. Bush JO, Jiang R. Palatogenesis: morphogenetic and molecular mechanisms of secondary palate development. Development 2012; 139: 231-243
3. Dixon MJ, Marazita ML, Beaty TH, Murray JC. Cleft lip and palate: understanding genetic and environmental influences. Nat Rev Genet 2011; 12: 167-178
4. Tan TY, Kilpatrick N, Farlie PG. Developmental and genetic perspectives on Pierre Robin sequence. Am J Med Genet C Semin Med Genet 2013; 163C: 295-305
5. Gordon CT, Tan TY, Benko S, Fitzpatrick D, Lyonnet S, Farlie PG. Long-range regulation at the SOX9 locus in development and disease. J Med Genet 2009; 46: 649-656
6. Leslie EJ, Marazita ML. Genetics of cleft lip and cleft palate. Am J Med Genet C Semin Med Genet 2013; 163C: 246-258
7. Seto-Salvia N, Stanier P. Genetics of cleft lip and/or cleft palate: association with other common anomalies. Eur J Med Genet 2014; 57: 381-393
8. Neiswanger K, Weinberg SM, Rogers CR et al. Orbicularis oris muscle defects as an expanded phenotypic feature in nonsyndromic cleft lip with or without cleft palate. Am J Med Genet A 2007; 143A: 1143-1149
9. Davidson TB, Sanchez-Lara PA, Randolph LM et al. Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature. BMC Med Genet 2012; 13: 19
10. Thienpont B, Mertens L, De Ravel T et al. Submicroscopic chromosomal imbalances detected by array-CGH are a frequent cause of congenital heart defects in selected patients. Eur Heart J 2007; 28: 2778-2784
11. Barbi G, Rossier E, Vossbeck S et al. Constitutional De novo interstitial deletion of 8Mb on chromosome 22q12.1-12.3 encompassing the neurofibromatosis type 2 (NF2) locus in a dysmorphic girl with severe malformations. J Med Genet 2002; 39: E6
12. Said E, Cuschieri A, Vermeesch J, Fryns JP. Toriello-Carey syndrome with a 6Mb interstitial deletion at 22q12 detected by array CGH. Am J Med Genet A 2011; 155A: 1390-1392
13. Bruder CE, Ichimura K, Blennow E et al. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?. Genes Chromosomes Cancer 1999; 25: 184-190
14. Bruder CE, Hirvela C, Tapia-Paez I et al. High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet 2001; 10: 271-282
15. Lekanne Deprez RH, Riegman PH, Groen NA et al. Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene 1995; 10: 1521-1528
16. Buijs A, Van Rompaey L, Molijn AC et al. The MN1-TEL fusion protein, encoded by the translocation (12; 22)(p13; q11) in myeloid leukemia, is a transcription factor with transforming activity. Mol Cell Biol 2000; 20: 9281-9293
17. Kandilci A, Surtel J, Janke L, Neale G, Terranova S, Grosveld GC. Mapping of MN1 sequences necessary for myeloid transformation. PloS One 2013; 8: e61706
18. Lai CK, Moon Y, Kuchenbauer F et al. Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 Oncogene. PloS One 2014; 9: e112671
19. Meester-Smoor MA, Vermeij M, Van Helmond MJ et al. Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton. Mol Cell Biol 2005; 25: 4229-4236
20. Reiter R, Brosch S, Ludeke M et al. Genetic and environmental risk factors for submucous cleft palate. Eur J Oral Sci 2012; 120: 97-103
21. Liu W, Lan Y, Pauws E et al. The Mn1 transcription factor acts upstream of Tbx22 and preferentially regulates posterior palate growth in mice. Development 2008; 135: 3959-3968
22. Braybrook C, Doudney K, Marcano AC et al. The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and ankyloglossia. Nat Genet 2001; 29: 179-183
23. Braybrook C, Lisgo S, Doudney K et al. Craniofacial expression of human and murine TBX22 correlates with the cleft palate and ankyloglossia phenotype observed in CPX patients. Hum Mol Genet 2002; 11: 2793-2804
24. Marcano AC, Doudney K, Braybrook C et al. TBX22 mutations are a frequent cause of cleft palate. J Med Genet 2004; 41: 68-74
25. Trofatter JA, MacCollin MM, Rutter JL et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993; 75: 826
26. Evans DG, Trueman L, Wallace A, Collins S, Strachan T. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet 1998; 35: 450-455
27. Watson CJ, Gaunt L, Evans G, Patel K, Harris R, Strachan T: A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus. Hum Mol Genet 1993; 2: 701-704
28. Yang HW, Kim TM, Song SS et al. Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma. Neoplasia 2012; 14: 20-28
29. Sestini R, Bacci C, Provenzano A, Genuardi M, Papi L. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mut 2008; 29: 227-231
30. Piotrowski A, Xie J, Liu YF et al. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet 2014; 46: 182-187
31. Toriello HV, Carey JC, Addor MC et al. Toriello-Carey syndrome: delineation and review. Am J Med Genet A 2003; 123A: 84-90
32. Toriello HV, Hatchwell E. Toriello-Carey syndrome phenotype and chromosome anomalies. Am J Med Genet A 2008; 146A: 116